Patents Assigned to Allergy Research Group, LLC
  • Patent number: 10421943
    Abstract: Sperm mobility and impregnation of an oocyte is enhanced by placing sperm in an aqueous solution of phospholipids prior to in vitro fertilization or artificial insemination. The aqueous phospholipid solution can also be used during storage or cryopreservation of the sperm. Also, the motility of sperm produced or ejaculated and the environment into which it is placed is enhanced my ingestion of the phospholipid composition by the male or female, or a vaginal placement of compositions containing the phospholipids.
    Type: Grant
    Filed: January 8, 2018
    Date of Patent: September 24, 2019
    Assignee: Allergy Research Group, LLC
    Inventors: Garth Nicolson, Gonzalo Ferreira de Mattos, Robert A. Settineri
  • Patent number: 10117885
    Abstract: Composition, preferably, in the form of capsules or chewable wafers in quantities suitable for relieving the symptoms of fibromyalgia comprise formulations of phospholipids, specifically identified concentrations of phosphatidylglycerol, phosphatidic acid, phosphatidylethanolamine, phosphatidylcholine, glycolipids and phosphatidylserine along with inulin and other desirable active ingredients are described.
    Type: Grant
    Filed: July 27, 2017
    Date of Patent: November 6, 2018
    Assignee: ALLERGY RESEARCH GROUP, LLC
    Inventor: Robert A. Settineri
  • Patent number: 9861656
    Abstract: Sperm mobility and impregnation of an oocyte is enhanced by placing sperm in an aqueous solution of phospholipids prior to in vitro fertilization or artificial insemination. The aqueous phospholipid solution can also be used during storage or cryopreservation of the sperm. Also, the motility of sperm produced or ejaculated and the environment into which it is placed is enhanced my ingestion of the phospholipid composition by the male or female, or a vaginal placement of compositions containing the phospholipids.
    Type: Grant
    Filed: September 2, 2016
    Date of Patent: January 9, 2018
    Assignee: ALLERGY RESEARCH GROUP, LLC
    Inventors: Garth Nicolson, Gonzalo Ferreira de Mattos, Robert A. Settineri
  • Patent number: 9717734
    Abstract: Flavored chewable wafers containing caffeine suitable for increasing alertness and allow an individual to perform tasks in a more focused and energetic manner comprises, formulations of phospholipids, specifically identified concentrations of phosphatidylglycerol, phosphatidic acid, phosphatidylethanolamine, phosphatidylcholine, glycolipids and phosphatidylserine along with inulin and other desirable active ingredients.
    Type: Grant
    Filed: October 17, 2016
    Date of Patent: August 1, 2017
    Assignee: ALLERGY RESEARCH GROUP, LLC
    Inventor: Robert Settineri
  • Patent number: 9468668
    Abstract: Flavored chewable wafers containing nutritional supplement formulations suitable for enhancement of cell and mitochondrial function as well as providing antioxidants and aiding in weight loss and other desirable nutritional benefits comprises enriched formulations of phospholipids, specifically identified concentrations of phosphatidylglycerol, phosphatidic acid, phosphatidylethanolamine, phosphatidylcholine, glycolipids and phosphatidylserine along with inulin and other desirable active ingredients. These edible wafer lipid combinations can be used to treat mitochondrial disorders and other nutritional deficiencies associated with medical pathologies, chronic illnesses and syndromes, or to maintain lipid balance for normal mitochondrial function, and can be administered in pleasant tasting chewable wafers.
    Type: Grant
    Filed: July 31, 2015
    Date of Patent: October 18, 2016
    Assignee: ALLERGY RESEARCH GROUP, LLC
    Inventor: Robert Settineri
  • Patent number: 9095507
    Abstract: An edible wafer containing nutritional supplement formulations suitable for specific enhancement of cell and mitochondrial function comprises enriched formulations of phospholipids or phospholipid chemical precursors containing inulin and specifically identified concentrations of phosphatidylglycerol, phosphatidic acid and phosphatidylcholine, and mitochondrial and cell membrane phospholipid molecules as well as other desirable constituents. These edible wafer lipid combinations can be used to treat mitochondrial disorders associated with medical pathologies, chronic illnesses and syndromes, or to maintain lipid balance for normal mitochondrial function, and can be administered in many different forms.
    Type: Grant
    Filed: January 10, 2014
    Date of Patent: August 4, 2015
    Assignee: Allergy Research Group, LLC
    Inventor: Robert A. Settineri